Altria Delivers 7.2% EPS Growth in 1H25 Despite Sales Headwinds
MO's first half of 2025 EPS grows 7.2% to $2.67 despite revenue declines, as pricing, efficiency gains and buybacks lifted margins and returns.
Altria Stock Trading at a Discount: What's the Next Best Move?
MO shows steady earnings and strong pricing power, though long-term momentum depends on balancing cigarette declines with smoke-free gains.
Altria Returns $4 Billion to Shareholders in First Half of 2025
MO has returned more than $4 billion to its shareholders in early 2025, fueled by strong dividends, buybacks and a solid balance sheet.
Mo's Smoke-Free Vision vs. Cigarette Declines: Is Transition on Track?
Altria shows cigarette volumes sliding while on! nicotine pouches surge in the second quarter, spotlighting the gradual shift toward smoke-free growth.
FDA To Expedite Nicotine Pouch Reviews In Pilot Program Under Trump Pressure: Report - Altria Group ( NYSE:MO ) , British American Tobacco ( NYSE:BTI )
The U.S. Food and Drug Administration ( FDA ) is reportedly set to launch a pilot program to fast-track the review of nicotine pouches from four major tobacco companies amid mounting pressure from the Trump administration.
Can on! Help Altria Capture More of the Booming Pouch Market?
MO's on! shipments jumped 26.5% in the second quarter, lifting its U.S. pouch share as marketing and earnings momentum intensify in a fast-growing market.
Should First Trust Dow Jones Select MicroCap ETF ( FDM ) Be on Your Investing Radar?
Style Box ETF report for ...
Philip Morris Transformation Accelerates With IQOS and ZYN Growth
PM's second-quarter results show smoke-free gains lifting revenues and profit, even as cigarette volumes continue to decline.
What's Driving Altria Group's Growth in OCI for Smokeables?
MO's smokeable margins jumped 2.9 percentage points to 64.5% as pricing power and cost cuts offset sharp volume declines.
Stoker's Launches Fine Cut Wintergreen in Convenient Can Format - Turning Point Brands ( NYSE:TPB )
LOUISVILLE, Ky., Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- Stoker's®, a leading brand in premium smokeless tobacco, has launched its popular Fine Cut Wintergreen in a convenient 1.2-ounce can, now in 15 states.
Altria Bets on Pricing: A Cushion Against Falling Volumes?
MO uses pricing strength to cushion profits against steep drops in cigarette volumes.
Should You Buy Altria Stock as it Hits a New 52-Week High?
MO hits a 52-week high on earnings growth, oral tobacco gains and rising investor confidence in its long-term strategy.
PM Stock Trades at Premium Value: Should You Buy, Hold or Sell?
Philip Morris' smoke-free growth is strong, but cigarette declines and a premium valuation urge cautious investment moves.
Philip Morris Aims for $2B Cost Savings by 2026: How Close Is It?
PM has already captured $1.2 billion in savings by mid-2025, keeping it on track to hit its $2 billion cost-cutting target by 2026.
Sin Stocks Worth Watching: The Perfect Mix of Growth & Resilience
Sin stocks like alcohol, tobacco and gambling remain resilient, offering stable demand, strong dividends and growth despite regulation and controversy.
Philip Morris' ILUMA Rollout: Will It Power H2 Volume Growth? ( Revised )
ILUMA's broader launch and expanded consumables range are contributing to PM's heated tobacco growth in 2025.
Philip Morris' ILUMA Rollout: Will It Power H2 Volume Growth?
ILUMA's broader launch and expanded consumables range are contributing to PM's heated tobacco growth in 2025.
Is on! Brand Growth Enough to Offset MST Declines at Altria?
MO's on! sales jump in the second quarter, but MST declines and pouch share losses raise questions about sustaining growth.
Turning Point ( TPB ) Q2 Sales Jump 25%
Turning Point Brands ( NYSE:TPB ) , the consumer products company known for its iconic tobacco and cannabis accessories brands, released its results for Q2 2025 on August 6, 2025. The quarter saw the company surpass Wall Street expectations with GAAP revenue of $116.6 million, well above the GAAP ...
MO Expands Smoke-Free Portfolio: Can It Offset Combustible Declines?
Altria's on! nicotine pouch shipments surge 26.5% in the second quarter, but can smoke-free gains offset cigarette declines?
Turning Point Brands ( TPB ) Q2 Earnings and Revenues Surpass Estimates
Turning Point Brands (TPB) delivered earnings and revenue surprises of +24.05% and +10.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
VEEV Volumes Double: Will Philip Morris' E-Vapor Bet Pay Off?
PM's VEEV shipments have more than doubled in the second quarter, with Europe driving growth and new markets showing early promise.
This Incyte Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Friday - Turning Point Brands ( NYSE:TPB ) , Incyte ( NASDAQ:INCY )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Needham analyst Gerald Pascarelli initiated coverage on Turning Point Brands, Inc.
Can ZYN and IQOS Sustain Philip Morris' Smoke-Free Surge?
IQOS and ZYN power PM's smoke-free growth in Q2, now accounting for more than 40% of revenues and gross profit.
Will Strong Pricing Power Offset Altria's Volume Declines in 2025?
Altria leans on strong pricing and Marlboro's brand power to offset a drop in cigarette volumes in the second quarter.
Altria ( MO ) Q2 Earnings and Revenues Surpass Estimates
Altria (MO) delivered earnings and revenue surprises of +5.11% and +1.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Altria's Q2 Earnings on the Deck: How to Play the Stock
MO's Q2 results are likely to reflect NJOY ACE's market exit and soft cigarette volumes, though pricing strength may help.
Here's Why Philip Morris Raises Its 2025 EPS Guidance Again
PM hikes its 2025 EPS guidance as smoke-free products like IQOS and ZYN boost the second-quarter performance.
Is on! the Bright Spot in Altria's Oral Tobacco Portfolio?
With rising brand loyalty and expanding reach, on! is reshaping MO's future in the oral nicotine space.
Philip Morris ( PM ) Q2 Earnings Top Estimates
Philip Morris (PM) delivered earnings and revenue surprises of +3.24% and -1.12%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Should Philip Morris Stock Be in Your Portfolio Ahead of Q2 Earnings?
PM's second quarter results are likely to benefit from strong pricing and sustained smoke-free momentum despite currency pressures.
Turning Point Brands ( TPB ) Soars 5.1%: Is Further Upside Left in the Stock?
Turning Point Brands (TPB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Behind Altria's Profit Resilience: The Power of Pricing Strategy
MO leans on pricing power to lift profits, offsetting cigarette volume drops and regulatory headwinds.
Is Philip Morris' Pricing Power Behind Its Profit Strength?
PM's strong pricing and premium product mix fuel profit growth and margin gains in the nicotine category.
Zig-Zag Launches New Premium Natural Leaf Cigar Line - Zig-Zag Woods - Turning Point Brands ( NYSE:TPB )
Los Angeles, California, July 08, 2025 ( GLOBE NEWSWIRE ) -- Zig-Zag Launches New Premium Natural Leaf Cigar Line - Zig-Zag Woods
Altria Group Gains 21% in 6 Months: How to Play the Stock?
MO is gaining ground with strong Marlboro pricing, smoke-free growth, and solid value, appealing to income-focused investors.
Philip Morris Gains 21% in 3 Months: How to Play the Stock?
PM is gaining ground with smoke-free products and cost cuts, but regulatory and currency risks call for caution.
MO Strengthens on! Brand: Can it Sustain Momentum in Nicotine Pouches?
Altria gains ground in smoke-free with on! pouches, lifting market share and boosting awareness through bold marketing moves.
PM Grows Smoke-Free Profit Share: Will Margins Keep Expanding?
Philip Morris' smoke-free shift gained momentum in the first quarter of 2025 as high-margin products drove profit growth and strengthened its portfolio mix.
FRE Nicotine Pouches Partners with PBR in the Brand's Largest-Ever Sports Sponsorship - Turning Point Brands ( NYSE:TPB ) , TKO Group Holdings ( NYSE:TKO )
Louisville, KY, July 02, 2025 ( GLOBE NEWSWIRE ) -- Some moments demand intensity, and few sports deliver it quite like Professional Bull Riders ( PBR ) . That's why FRE® Nicotine Pouches is stepping into the arena as an official partner of Unleash The Beast, the sport's premier individual series.
Top 3 Tobacco Stocks to Watch Amid Strong Industry Growth Trends
PM, MO and TPB are riding a wave of RRP innovation and pricing power as the tobacco industry pivots toward smoke-free growth.
Can Philip Morris Rely on Pricing to Drive 2025 EPS Growth?
PM lifts its 2025 EPS forecast after a strong first quarter, but can pricing alone keep driving growth through year-end?
Altria Trades at a Bargain: Is it a Good Time to Buy the Stock?
MO trades at a steep discount to peers and shows bullish momentum, making it a potential value play in tobacco's shift to smoke-free.
Philip Morris Stock Records 50% YTD Surge: Is it Too Late to Buy?
PM stock soars 50.1% year to date, fueled by smoke-free growth, premium pricing and bullish earnings momentum.
Is Altria's Post Q1 Earnings Stock Dip a Green Light for Investors?
MO is backed by strong fundamentals, pricing power and long-term growth potential in smoke-free products.
PM Stock Up 6.9% Post Q1 Earnings: A Green Light for Investors?
PM shows strong growth prospects, driven by its successful shift to smoke-free products, solid first-quarter results and optimistic guidance.
Turning Point Brands ( TPB ) Q1 Earnings and Revenues Top Estimates
Turning Point Brands (TPB) delivered earnings and revenue surprises of 21.33% and 11.92%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
The Next Botanical Poised For Breakout Like CBD
Wellness trends often emerge at the fringes of mainstream attention-passed between friends, spotlighted in boutique retailers, or debated in digital communities. From adaptogenic mushrooms to CBD, the path is familiar: niche adoption turns to broader interest, and eventually, market boom.
Should Altria Stock Be in Your Portfolio Ahead of Q1 Earnings?
MO's Q1 results are likely to reflect macroeconomic pressures and declining cigarette volumes, though growth in smoke--free products may help.
Altria Trading at a Discount: Should You Buy, Sell or Hold the Stock?
MO's low valuation reflects structural challenges, making it a risky bet amid declining volumes, regulatory pressure, and rising illicit competition.
